Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41
Early research (Phase 1)Ended earlyNCT02782403
What this trial is testing

Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia (CML)Blast Phase Chronic Myelogenous Leukemia (CML)Chronic Phase Phase Chronic Myelogenous Leukemia (CML)+1 more
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT03625388
What this trial is testing

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hikma Pharmaceuticals LLC 56
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Large-scale testing (Phase 3)Ended earlyNCT02115386
What this trial is testing

Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib

Who this might be right for
Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
Novartis Pharmaceuticals 7
Not applicableUnknownNCT03933852
What this trial is testing

Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
University of Jena 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147612
What this trial is testing

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia With BCR-ABL1+3 more
M.D. Anderson Cancer Center 22
Early research (Phase 1)Study completedNCT01751919
What this trial is testing

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumor
Dong-A ST Co., Ltd. 37
Early research (Phase 1)Study completedNCT02352558
What this trial is testing

BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Sumitomo Pharma America, Inc. 15
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)UnknownNCT00199186
What this trial is testing

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Philadelphia Positive Acute Lymphoblastic LeukemiaLymphoid Blastic Phase of Chronic Myeloid Leukemia
Johann Wolfgang Goethe University Hospital
Testing effectiveness (Phase 2)Study completedNCT00858806
What this trial is testing

Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 78
Testing effectiveness (Phase 2)Study completedNCT03455517
What this trial is testing

Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 77
Not applicableLooking for participantsNCT07375355
What this trial is testing

Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China

Who this might be right for
Chronic Myeloid Leukemia in Chronic Phase
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Ended earlyNCT02398825
What this trial is testing

Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib

Who this might be right for
Chronic Myeloid LeukemiaChronic PhaseAdults
Gruppo Italiano Malattie EMatologiche dell'Adulto 14
Large-scale testing (Phase 3)Study completedNCT00123474
What this trial is testing

Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML

Who this might be right for
Myeloid Leukemia, Chronic, Chronic-Phase
Bristol-Myers Squibb 724
Testing effectiveness (Phase 2)Study completedNCT00381550
What this trial is testing

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00002809
What this trial is testing

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Temple University 10
Testing effectiveness (Phase 2)UnknownNCT01690065
What this trial is testing

Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML

Who this might be right for
Chronic Myeloid Leukemia in Myeloid Blast CrisisUntreated Adult Acute Myeloid Leukemia
Ulsan University Hospital 46
Not applicableUnknownNCT05926128
What this trial is testing

Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
CML
Fundaleu 75
Next Page